Navigation Links
PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S.
Date:7/21/2008

Clinical study and limited launch in Italy continue

FRANKLIN, Mass., July 21 /PRNewswire-FirstCall/ -- PLC Systems Inc. (Amex: PLC) announced today that it will defer the commencement of the U.S. pivotal trial of its RenalGuard(TM) System in the prevention of Contrast-Induced Nephropathy (CIN). The company continues to support the investigator-sponsored clinical trial now ongoing in Milan, Italy as well as the limited market launch of RenalGuard in Europe, which began in the first quarter of this year, both of which are focused on the CIN prevention market.

Mark R. Tauscher, President and Chief Executive Officer of PLC, said, "We are taking this action now because, while we have sufficient funds to commence the U.S. pivotal trial at this time, we believe we will be in a better position to successfully raise the funding necessary to complete the trial and prepare for U.S. market launch in the future, once we have the expected positive clinical data from the study currently underway in Italy at the Centro Cardiologico Monzino-University of Milan (CCM). For these reasons, after consultation with our lead U.S. investigators, we have elected to postpone the start of the U.S. pivotal trial. We anticipate that this deferral will reduce the expected increase in our research and development costs that we had previously estimated for the remainder of 2008, as we lower our expenses associated with clinical trial oversight and management."

Mr. Tauscher added, "In the meantime, we are continuing our dual commercialization strategy for RenalGuard. First and foremost, we are continuing to work with the U.S. Food and Drug Administration to secure a full approval of our RenalGuard study protocol so that we are well-positioned t
'/>"/>

SOURCE PLC Systems Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
2. PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
3. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
4. PLC Systems Reports Fourth Quarter 2007 Results
5. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
6. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
7. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
8. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
9. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
10. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
11. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Fla. , March 3, 2015 ... pleased to announce the hiring of Brian ... to lead business development efforts and build relationships ... of experience in software development, sales, and sales ... enterprise software applications. iTraycer is a comprehensive inventory ...
(Date:3/3/2015)... -- Dr. Cummins is known for being one of ... In addition to performing cosmetic and hand surgery at ... Cummins now offers advanced laser tattoo removal treatments at ... performs all treatments himself using the industry-leading Astanza Duality ... order to help people take back control over the ...
(Date:3/3/2015)... --   Clinical trials at ... Publications in peer reviewed journals Gastrointestinal Endoscopy ... diagnostic value of confocal laser endomicroscopy in treatment of ... across Asia   ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today ...
Breaking Medicine Technology:Medical Tracking Solutions, Inc. Hires New SVP, Sales 2Surgeon Owned And Operated Louisville Tattoo Removal Offers Astanza Duality Laser Treatments 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4
... Disease Research Interchange, a Philadelphia-based national human tissue center ... awarded a $3.59 million subcontract from the National Institutes ... (Genotype-Tissue Expression). The funds for the 30-month project are ... NCI (the National Cancer Institute), NIMH (the National Institute ...
... FOUNTAIN HILLS, Ariz., Oct. 13 Sunridge International (OTC ... received an order for additional inventory from New Amsterdam ...  New Amsterdam personnel are currently on a two-week marketing ...  New Amsterdam,s personnel is accompanied by Leo D. Bores ...
Cached Medicine Technology:NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, 'The Directors Common Fund' to Provide Human Tissue for 'GTEx,' the New Genotype-Tissue Expression Project 2NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, 'The Directors Common Fund' to Provide Human Tissue for 'GTEx,' the New Genotype-Tissue Expression Project 3NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, 'The Directors Common Fund' to Provide Human Tissue for 'GTEx,' the New Genotype-Tissue Expression Project 4
(Date:3/3/2015)... The human augmentation market is mainly driven ... wearable augmentation sector is predicted to outpace the in-built ... years. , The eye-wear sector dominates the North ... of new products launches in the region. Furthermore, strong ... as well as the rising demand for advantageous products ...
(Date:3/3/2015)... While it is clear that the prospect of reduced ... are signing up to UBI policies, more mature audiences ... Due to current regulations, the application of UBI in ... full capability is starting to be realised in the ... services are at the top of the value-added services ...
(Date:3/3/2015)... 03, 2015 DePuy Pinnacle hip ... version of the artificial hip system caused recipients ... move forward in the federal multidistrict litigation underway ... According to the most recent Master Case List ... 7,350 Pinnacle hip replacement lawsuits are now pending ...
(Date:3/3/2015)... BC (PRWEB) March 03, 2015 The ... doubled since 1984 to about 15%. This increases to ... old. (Bushnik T, Cook JL, Yuzpe AA, et al. ... 2012; 27: 738-46). Dr. Jason Hitkari, a reproductive endocrinologist ... a doctor of TCM and clinical director and founder ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... is estimated to grow from $1,224.6 million ... 6.71% between 2014 and 2019. , Browse ... delivery network market for an analysis of ... of various tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html ...
Breaking Medicine News(10 mins):Health News:Human Augmentation Market to Pose 43.5% CAGR Through 2020, States MarketsandMarkets in its New Research Study Now Available at MarketPublishers.com 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3
... HOPKINTON, Mass., Sept. 14 EMC Corporation (NYSE: ... infrastructure solutions, today announced that eClinicalWorks, a market leader ... provider customers, has consolidated and enhanced security of its ... As a result, eClinicalWorks has successfully managed rapid business ...
... , , ITASCA, Ill., Sept. 14 ... the JEWEL-OSCO grocery checkout. , , Starting today ... pharmacy will receive a special invitation to save a total of 20 ... avoid serious complications that can result from certain other illnesses or health conditions. ...
... , , , ... revealing that ten percent of Americans face dangerous drinking water, the Water ... their homes. , , On Sunday, the newspaper reported ... on "toxic waters." Among its findings: , , ...
... WILMINGTON, Del., Sept. 14 The airline and pharmaceutical industries ... can be dangerous if the risks are not properly calculated and ... experience of people who make and fly airplanes? , , ... a recent webinar on the topic - Captain Ben Berman, senior ...
... , , , ... today announced it has received the Frost & Sullivan 2009 ... of the Year Award . The award highlights PolyOne,s continuous innovations ... Walter Ripple, general manager, PolyOne,s GLS Thermoplastic Elastomers (TPEs), ...
... CHERRY HILL, N.J., Sept. 14 Nuvilex, Inc. (OTC Bulletin ... sponsored research studies indicate that Oraphyte(TM) can control nematode infestation ... coming months Nuvilex intends to initiate trials on golf course ... most optimal for turfgrass growth. These commercial studies will determine ...
Cached Medicine News:Health News:eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 2Health News:eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 3Health News:JEWEL-OSCO PHARMACY Offers Grocery Savings to Flu Shot Customers 2Health News:Home Filtering Systems Provide Best Drinking Water Protection 2Health News:Webinar Explores Drug Safety Lessons Pharma Can Learn from Airline Industry 2Health News:PolyOne Presented with Frost & Sullivan Medical Product Award 2Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 2Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 3Health News:Nuvilex, Inc. Announces Positive Oraphyte(TM) Microplot Results 4
ELISA kit for Varicella-zoster IgM....
ELISA kit for Varicella-zoster IgG....
The DSL-05-10-VZM Varicella Zoster IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Varicella Zoster Virus in human serum. This as...
... Scientific, Inc. Mumps IgG ELISA test system ... Mumps IgG antibody in human serum. When ... of this test, together with other clinical ... immune status, and/or aid in the diagnosis ...
Medicine Products: